Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell
• Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
What’s Going On With Geron Stock Today
Geron Corporation (NASDAQ: GERN) submitted a marketing application with the FDA seeking approval for imetelstat for the treatment of transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes who have failed to respond or have lost response to or are ineli
Geron Announces ASCO Presentation Reporting Durable Continuous Transfusion Independence With Imetelstat In IMerge Phase 3 Lower Risk MDS Patients
Primary endpoint of 8-week transfusion independence (TI) significantly higher with imetelstat vs. placebo (P<0.001), with median TI duration approaching one year for imetelstat 8-week TI responders
Statistically
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell
• Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter.
• Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
Recap: Geron Q1 Earnings
Geron (NASDAQ:GERN) reported its Q1 earnings results on Thursday, May 11, 2023 at 08:00 AM. Here’s what investors…
A Preview Of Geron’s Earnings
Geron (NASDAQ:GERN) is set to give its latest quarterly earnings report on Thursday, 2023-05-11. Here’s what investors need…
Geron Announces Upcoming Oral Presentation At 2023 American Society Of Clinical Oncology Annual Meeting Of Imetelstat Data From IMerge Phase 3 Lower Risk MDS Trial
Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced that data from the pivotal IMerge Phase 3 clinical trial evaluating the Company's first-in-class telomerase inhibitor,